Has David Goldman received payments from drug or device companies?

Yes. Drug and device makers reported $12,371 in general payments to David Goldman across 543 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Goldman did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Goldman come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Goldman

Internal Medicine · Knoxville, TNNPI 1518047059

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,556 of the $12,371 with a category attached, or 77.2%. It is spread thinly across 58 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $4,622 and has fallen 98.3% since, to $80 in 2025. Among internal medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,371in general payments, 2019–2025

Across 543 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Optos, Inc.$3K
AbbVie$1K
Novo Nordisk$1K
GSK$760
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$651
AstraZeneca$639
plus $6K from 52 others

What the payments were for

Speaking & faculty fees$2,69322%
Food & beverage$9,55677%
Education$1221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Optos, Inc.	2	$2,500
AbbVie(2 entities)	70	$1,195
Novo Nordisk	78	$1,079
GSK	35	$760
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	29	$651
AstraZeneca	35	$639
Pfizer	33	$551
Johnson & Johnson	6	$401
Amarin Pharma, Inc.	27	$400
Abbott	16	$279
Teva Pharmaceuticals USA, Inc.	5	$273
Smith+Nephew	7	$262
Lilly USA, LLC	22	$257
Boehringer Ingelheim	19	$248
Mannkind Corporation	9	$244
Takeda Pharmaceuticals U.S.A., Inc.	17	$242
Dexcom, Inc.	7	$232
Xeris Pharmaceuticals, Inc.	9	$182
Amgen(2 entities)	10	$178
Antares Pharma, Inc.	8	$160
Astellas Pharma US Inc	4	$156
Merck	9	$128
Sanofi-aventis U.S. LLC	7	$100
Alkermes, Inc.	5	$88
Zealand Pharma US, Inc.	4	$86
Medtronic(3 entities)	5	$70
Tris Pharma Inc	4	$59
Biohaven Pharmaceutical Holding Company Ltd.	4	$58
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$56
Mylan Specialty L.p.	4	$56
Nestle Healthcare Nutrition Inc.	3	$53
Biohaven Pharmaceuticals, Inc.	3	$52
Esperion Therapeutics, Inc.	3	$51
Paratek Pharmaceuticals, Inc.	3	$47
Vanda Pharmaceuticals Inc.	2	$45
Clarus Therapeutics Inc.	4	$42
Daiichi Sankyo Inc.	2	$42
Valeritas, Inc.	3	$41
Novartis	3	$37
Bayer	2	$34
Nevro Corp.	2	$30
Exact Sciences	2	$27
Biogen	2	$27
Zyla Life Sciences, Inc.	2	$24
Axsome Therapeutics, Inc.	1	$24
E.r. Squibb & Sons, L.L.C.	1	$21
GRT US Holding, Inc.	1	$20
Ironshore Pharmaceuticals Inc.	1	$20
Medartis Inc.	1	$18
Melinta Therapeutics, LLC	1	$17
Convatec Inc.	1	$16
KCI USA, Inc.	1	$15
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$15
Ironwood Pharmaceuticals, Inc	1	$14
Lundbeck LLC	1	$14
Insulet Corporation	1	$14
Bausch Health US, LLC	1	$13
Acadia Pharmaceuticals Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,371 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate	24	$610
Omeprazole	27	$435
Atorvastatin Calcium	60	$425
Levothyroxine Sodium	51	$357
Fenofibrate	11	$266
Rosuvastatin Calcium	18	$235
Amlodipine Besylate	33	$208
Losartan Potassium	21	$178
Fluticasone Propionate	12	$162
Pantoprazole Sodium	11	$149
ClopidogrelClopidogrel Bisulfate	14	$134
Metformin Hcl ErMetformin Hcl	13	$129
Simvastatin	21	$91
Lisinopril	17	$69
Metoprolol Tartrate	16	$66

Paid to pharmacies, not to this prescriber.

Other internal medicine in Knoxville

Dennis DeruelleKnoxville$263K
Lewis HagoodKnoxville$143K
Antonio RamosKnoxville$20K
Michael CollierKnoxville$17K
John AndersonNashville$1.5M
Tracie WalkerJackson$488K
Nathan TrenthamEtowah$404K
Devin ShermanFranklin$191K
Temidayo AbeNashville$113K
Kenya KozawaSweetwater$86K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →